<DOC>
	<DOCNO>NCT01556100</DOCNO>
	<brief_summary>A total 40 PD subject include study . PD subject 20 80 year age may eligible study . Candidates screen medical history physical examination , blood test .</brief_summary>
	<brief_title>Long-Term Vesicular Monoamine Transporter II Imaging Clinical Assessment Parkinson 's Disease Progression</brief_title>
	<detailed_description>The primary objective protocol ass rate change striatal 18F-DTBZ uptake cohort Parkinson 's disease patient . This study expect completed period 4 year .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<criteria>1 . Male female age 20 year 80 year . 2 . Patients fulfil Criteria diagnosis Parkinson disease `` possible '' `` probable '' PD1 . 3 . Patients provide write informed consent prior study entry . If patient incapable informed consent , caregiver may consent behalf patient ( patient must still confirm assent ) Exclusion criterion : 1 . Significant recent ( within 6 month ) history neurological ( include stroke brain trauma ) psychiatric disorder . 2 . Alcohol substance abuse . 3 . History presence QTc prolongation . ( &gt; 500msec ) 4 . History intracranial operation , include thalamotomy , pallidotomy , and/or deep brain stimulation . 5 . Unable stay still MRI PET scanner 30 minute . 6 . Pregnancy breast feed . 7 . Hepatic dysfunction liver function test ( alanine aminotransferase [ ALT ] aspartate aminotransferase [ AST ] ) &gt; 3x upper limit normal</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>18F-DTBZ AV-133 imaging</keyword>
</DOC>